M

Millendo Therapeutics

8 employees

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
pharmaceuticals
Endocrinology
Life Science
biotech

Date founded

2011

Funding rounds raised

Total raised

$62M

from 13 investors over 13 rounds

M

Millendo Therapeutics raised $30M on August 9, 2018

Investors: Adams Street Partners, Osage University Partners (OUP), Longwood Fund and Frazier Healthcare Partners

M

Millendo Therapeutics raised $62M on January 5, 2016

Investors: Frazier Healthcare Partners, Longwood Fund, Osage University Partners (OUP), 5AM Ventures, Adams Street Partners and Renaissance Venture Capital Fund

M

Millendo Therapeutics raised $16M on August 3, 2012

Investors: 5AM Ventures, Frazier Healthcare Partners and Osage University Partners (OUP)

FAQ